What this shows is what I've been saying forever: We need to legislatively remove software from patent eligibility, so that biotech firms and big pharma are on their own. Having them in the debate makes our task nearly impossible.
> It is a patent eligibility law that would, in essence, restore the ability of inventors to patent software and biotech inventions
I agree. I don't really know enough about biotech to have an opinion on that, but when it comes to software, I think that software patents are not only difficult to support in terms of what patents are supposed to do, but are harmful for the software industry and society all around.